Titel,Autor,Reference,year,sample,samplesize,SZn,HCn,Meds (CPZeq) ,MedsSD (CPZeq) ,Meds,ROI tracing method,region of interest,toolbox,sequence,scanner type,study type,measurement in ROI,normalization,HCmean,HCsd,HCmean_LC,HCsd_LC,SZmean,SZsd,SZmean_LC,SZsd_LC,age_HC,age_HCsd,age_SZ,age_SZsd,HC Gender (M:F),SZ Gender (M:F),matched (age),matched (gender),reference region,contrast calculated (order for means/SD)
Neuromelanin Magnetic Resonance Imaging RevealsIncreased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia,Watanabe (2014),"Watanabe Y, Tanaka H, Tsukabe A, Kunitomi Y, Nishizawa M, Hashimoto R, et al. Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. PLoS One. 2014;9(8):1–6. ",2014,SCZ/HC,52,52,52,596.20,556.20,1.00,manually drawn,SN,,magnetization transfer,3 TE GE,cases control,CR_SNc,none,9.60,2.36,13.44,3.37,10.89,2.37,14.21,3.50,34.60,13.70,35.10,13.30,27:25,27:25,x,x,midbrain tegmentum,
1) Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain: unmedicated SZ group,Cassidy (2019) - SCZ,"Cassidy CM, Zucca FA, Girgis RR, Baker SC, Weinstein JJ, Sharp ME, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci U S A. 2019;116(11):5108–17. ",2019,SCZ/HC,"psychosis part of study: SZ unmedicated: 33, CHR: 25, HC: 30 + 15 (matched)",33,30,NA,NA,0.00,masks,whole SN,,"T1-weighted 3D BRAVO sequence, T2-weighted CUBE sequence",GE Healthcare 3T MR750 scanner,case control ,CR_SNc,DARTEL,16.16,2.74,NA,NA,16.17,1.89,NA,NA,34.00,2.20,33.90,2.20,(18:12),(23:10),x,- ,crus cerebri,CNRvoxel = (Ivoxel −mode(IRefRegion) / mode(IRefRegion)
2) Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain: CHR group,Cassidy (2019) - CHR,"Cassidy CM, Zucca FA, Girgis RR, Baker SC, Weinstein JJ, Sharp ME, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci U S A. 2019;116(11):5108–17. ",2019,CHR/HC,"psychosis part of study: SZ unmedicated: 33, CHR: 25, HC: 30 + 15 (matched)",25,15,NA,NA,0.00,masks,SN,,"T1-weighted 3D BRAVO sequence, T2-weighted CUBE sequence",GE Healthcare 3T MR750 scanner,case control ,CR_SNc,DARTEL,15.47,2.59,NA,NA,15.47,1.82,NA,NA,23.50,0.86,25.60,0.97,(9:6),(13:12),,,,
Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus,Shibata (2008),"Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, et al. Use of Neuromelanin-Sensitive MRI to Distinguish Schizophrenic and Depressive Patients and Healthy Individuals Based on Signal Alterations in the Substantia Nigra and Locus Ceruleus. Biol Psychiatry. 2008 Sep 1;64(5):401–6. ",2008,medicated patients MD and SZ,"20SZ,18MD, 34 HC",20,34,671.00,572.00,1.00,manually drawn,SN and LC,,FSE,3TE GE,case control,"CR_SNc, CR_CRLC",none,19.60,3.80,11.00,3.90,22.60,5.60,10.00,3.10,43.80,11.20,44.60,15.20,17:17,13:7,x,-,"SCP decussation, pontine tegmentum",
Detection of changes in the ventral tegmental area of patients with schizophrenia using neuromelanin-sensitive MRI,Yamashita (2016),"Yamashita F, Sasaki M, Fukumoto K, Otsuka K, Uwano I, Kameda H, et al. Detection of changes in the ventral tegmental area of patients with schizophrenia using neuromelanin-sensitive MRI. Neuroreport. 2016 Feb 23;27(5):289–94.",2016,HC/SCZ,"14 SCZ, 22 HC",14,22,263.00,NA,1.00,manually drawn ,"VTA, SNc",SPM,NM-sensitive T1-weighted FSE,3T,case control,"CR_SNc, CR_CRLC",advanced normalization tools (ANTs),1098,10.00,NA,NA,1093,6,NA,NA,40.00,NA,37.00,,14:8,11:3,x,-,superior cerebellar peduncle,"SNc, VTA, VTA/SNc ratio"
Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging,Sasaki (2010),"Sasaki M, Shibata E, Ohtsuka K, Endoh J, Kudo K, Narumi S, et al. Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging. Neuroradiology. 2010;52(2):83–9. ",2010,HC/MDD/SCZ,23 each group,23,23,656.00,537.00,1.00,manually drawn,"LC, SNc",ExaVision,NM-sensitive T1-weighted FSE,3T,case control,"CR_SNc, CR_CRLC",none,20.5,3.40,10.9,3.2,22.6,5.1,9.8,3.4,47,16.9,44.9,13.6,10:23,15:23,x,-,"SCP decussation, pontine tegmentum",
Neuromelanin changes in first episode psychosis with substance abuse,Jalles (2020),"Jalles C, Chendo I, Levy P, Reimao S. Neuromelanin changes in first episode psychosis with substance abuse. Schizophr Res. 2020;220(xxxx):283–4. ",2020,FEP/HC,"30 schizophreniform,8 HC",30,8,NA,NA,0.00,,SN and LC,,as Sasaki (2006),3T,case control,"CR_SN, CR_CRLC",NA,13.26,2.55,NA, NA,15.16,4.52,NA,NA,25.63,4.24,23.07,4.72,5:5,21:9,-,-,-,